LncRNA-SERB promotes vasculogenic mimicry (VM) formation and tumor metastasis in renal cell carcinoma

A growing body of evidence shows that vasculogenic mimicry (VM) is closely related to the invasion and metastasis of many tumor cells. Although the estrogen receptor (ER) can promote initiation and progression of renal cell carcinoma (RCC), how the downstream biomolecules are involved, and the detailed mechanisms of how ER expression is elevated in RCC remain to be further elucidated. Here, we discovered that long noncoding RNA (LncRNA)-SERB is highly expressed in tumor cells of RCC patients. We used multiple RCC cells and an in vivo mouse model for our study, and results indicated that LncRNA-SERB could boost RCC VM formation and cell invasion in vitro and in vivo. Although a previous report showed that ER(3 can affect the VM formation in RCC, it is unclear which factor could upregulate ER(3. This is the first study to show LncRNA-SERB can be the upstream regulator of ER(3 to control RCC progression. Mechanistically, LncRNA-SERB may increase ER(3 via binding to the promoter area, and ER(3 functions through transcriptional regulation of zinc finger Ebox binding homeobox 1 (ZEB1) to regulate VM formation. These results suggest that LncRNA-SERB promotes RCC cell VM formation and invasion by upregulating the ER(3/ZEB1 axis and that therapeutic targeting of this newly identified pathway may better inhibit RCC progression.